Literature DB >> 33902786

Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.

Niamh Allen1, Una Ni Riain2, Niall Conlon1, Annamaria Ferenczi3, Antonio Isidro Carrion Martin4, Lisa Domegan3, Cathal Walsh3,5,6, Lorraine Doherty3, Cliona O'Farrelly7, Eibhlin Higgins8, Colm Kerr1, Jonathan McGrath1, Catherine Fleming8, Colm Bergin1.   

Abstract

Hospital healthcare workers (HCWs) are at increased risk of contracting COVID-19 infection. We aimed to determine the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in HCWs in Ireland. Two tertiary referral hospitals in Irish cities with diverging community incidence and seroprevalence were identified; COVID-19 had been diagnosed in 10.2% and 1.8% of staff respectively by the time of the study (October 2020). All staff of both hospitals (N = 9038) were invited to participate in an online questionnaire and blood sampling for SARS-CoV-2 antibody testing. Frequencies and percentages for positive SARS-CoV-2 antibody were calculated and adjusted relative risks (aRR) for participant characteristics were calculated using multivariable regression analysis. In total, 5788 HCWs participated (64% response rate). Seroprevalence of antibodies to SARS-CoV-2 was 15% and 4.1% in hospitals 1 and 2, respectively. Thirty-nine percent of infections were previously undiagnosed. Risk for seropositivity was higher for healthcare assistants (aRR 2.0, 95% confidence interval (CI) 1.4-3.0), nurses (aRR: 1.6, 95% CI 1.1-2.2), daily exposure to patients with COVID-19 (aRR: 1.6, 95% CI 1.2-2.1), age 18-29 years (aRR: 1.4, 95% CI 1.1-1.9), living with other HCWs (aRR: 1.3, 95% CI 1.1-1.5), Asian background (aRR: 1.3, 95% CI 1.0-1.6) and male sex (aRR: 1.2, 95% CI 1.0-1.4). The HCW seroprevalence was six times higher than community seroprevalence. Risk was higher for those with close patient contact. The proportion of undiagnosed infections call for robust infection control guidance, easy access to testing and consideration of screening in asymptomatic HCWs. With emerging evidence of reduction in transmission from vaccinated individuals, the authors strongly endorse rapid vaccination of all HCWs.

Entities:  

Keywords:  COVID-19; Coronavirus; SARS-CoV-2 antibodies; healthcare workers; seroprevalence

Year:  2021        PMID: 33902786     DOI: 10.1017/S0950268821000984

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  5 in total

1.  Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy.

Authors:  Stefania Paduano; Pasquale Galante; Nausicaa Berselli; Luca Ugolotti; Alberto Modenese; Alessandro Poggi; Marcella Malavolti; Sara Turchi; Isabella Marchesi; Roberto Vivoli; Paola Perlini; Rossana Bellucci; Fabriziomaria Gobba; Marco Vinceti; Tommaso Filippini; Annalisa Bargellini
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

2.  Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.

Authors:  Niamh Allen; Melissa Brady; Una Ni Riain; Niall Conlon; Lisa Domegan; Antonio Isidro Carrion Martin; Cathal Walsh; Lorraine Doherty; Eibhlin Higgins; Colm Kerr; Colm Bergin; Catherine Fleming
Journal:  Front Med (Lausanne)       Date:  2022-02-04

3.  Cumulative incidence, prevalence, seroconversion, and associated factors for SARS-CoV-2 infection among healthcare workers of a University Hospital in Bogotá, Colombia.

Authors:  Sandra Liliana Valderrama-Beltrán; Juliana Cuervo-Rojas; Beatriz Ariza; Claudia Cardozo; Juana Ángel; Samuel Martinez-Vernaza; María Juliana Soto; Julieth Arcila; Diana Salgado; Martín Rondón; Magda Cepeda; Julio Cesar Castellanos; Carlos Gómez-Restrepo; Manuel Antonio Franco
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

4.  Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.

Authors:  Carolina De Marco Verissimo; Carol O'Brien; Jesús López Corrales; Amber Dorey; Krystyna Cwiklinski; Richard Lalor; Jack M Doyle; Stephen Field; Claire Masterson; Eduardo Ribes Martinez; Gerry Hughes; Colm Bergin; Kieran Walshe; Bairbre McNicholas; John G Laffey; John P Dalton; Colm Kerr; Sean Doyle
Journal:  Epidemiol Infect       Date:  2021-06-08       Impact factor: 2.451

5.  SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.

Authors:  Niamh Allen; Melissa Brady; Antonio Isidro Carrion Martin; Lisa Domegan; Cathal Walsh; Elaine Houlihan; Colm Kerr; Lorraine Doherty; Joanne King; Martina Doheny; Damian Griffin; Maria Molloy; Jean Dunne; Vivion Crowley; Philip Holmes; Evan Keogh; Sean Naughton; Martina Kelly; Fiona O'Rourke; Yvonne Lynagh; Brendan Crowley; Cillian de Gascun; Paul Holder; Colm Bergin; Catherine Fleming; Una Ni Riain; Niall Conlon
Journal:  Microbiol Spectr       Date:  2021-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.